the Dexcom G7 CGM system is more accessible to qualifying insulin-treated Medicare patients than ever before^†

No other CGM system is more affordable than  Dexcom G7 for Medicare patients*

AND 3 OUT OF 4 MEDICARE ADVANTAGE PATIENTS PAY $0 AT THE PHARMACY^‡,1

DME Distributors: Dexcom CGM is available for Medicare FFS patients nationwide

shipping truck Dexcom G7 can be shipped or
conveniently delivered to a
patient’s home

Medicare Health Insurance Card

DME Distributors & Pharmacies: Dexcom CGM is available for Medicare Advantage patients nationwide for plans including:

United Healthcare, Cigna Healthcare, CVS Health Aetna Humana,

Medicare and Medicare Advantage patients may be eligible for Dexcom G7 if they meet the following criteria:

the patient has been diagnosed with diabetes and is
treated with any insulin

the patient has a history of hypoglycemia with
documentation of either:

-one or more hypoglycemic events (level 2 hypoglycemia)i
-one hypoglycemic event (level 3 hypoglycemia)i

Dexcom Warrior Karyn

how to prescribe the Dexcom G7 CGM system for
Medicare patients

follow these four simple steps to get your Medicare patients started quickly on Dexcom G7:

ensure that the chart notes verify that the Medicare patient meets the criteria above

send the patient’s prescription/certificate of medical necessity, and chart notes to one of the distributors listed below

let your patient know that they will be contacted by the distributor regarding their Dexcom G7 order

make sure your patient has an in-person visit within 6 months of starting CGM and every 6 months thereafter

DISTRIBUTOR	PHONE NUMBER	FAX NUMBER
Byram Healthcare	800-775-4372	888-457-1277
CCS Medical	800-949-6481	800-557-8256
Solara Medical Supplies	800-423-0896 opt 2	800-999-7021
Edgepark	866-400-5183 opt 2	866-510-6583
Edwards Health Care Services	888-344-3434	502-657-0237
Advanced Diabetes Supply	877-838-3026	760-444-8771

get your patients

started for free today

PRESCRIBE & SAMPLE

have additional

Medicare questions?

MEDICARE FAQS

CGM = continuous glucose monitoring; DME = durable medical equipment; FFS = fee for service.

*Under Medicare’s DME fee schedule, reimbursement and coinsurance for CGMs using CPT codes A4239 and E2103 are the same, regardless of CGM brand. †The local coverage determination expands coverage of CGM and related supplies to Medicare beneficiaries treated with insulin at least once daily or with a history of problematic hypoglycemia. For the full list of Medicare coverage criteria, visit the Centers for Medicare and Medicaid Services website. ‡Individual pricing may vary depending on insurance coverage.

1 Dexcom, Data on File, 2024.

MAT-5856

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Request Purchasing Info for a Stelo Bulk Order

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

the Dexcom G7 CGM system is more accessible to qualifying insulin-treated Medicare patients than ever before†

Contact Us

the Dexcom G7 CGM system is more accessible to qualifying insulin-treated Medicare patients than ever before^†